// App-Quantinova.ai

P691 : MODELLING OF IMMUNE RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS SUGGESTS POTENTIAL FOR TREATMENT REDUCTION PRIOR TO CESSATION

Researchers

Presenter

  • Elena Karg

Principal Investigators

  • Christoph Baldow

  • Thomas Zerjatke

  • Richard E Clark

  • Ingo Roeder

  • Artur C Fassoni

  • Ingmar Glauche

Medical Centers

  • Institute for Medical Informatics and Biometry (IMB),TU Dresden,Dresden,Allemagne

  • Instituto de Matemática e Computação,Universidade Federal de Itajubá,Itajubá,巴西

  • Instituto de Matemática e Computação,Universidade Federal de Itajubá,Itajubá,巴西

  • Institute for Medical Informatics and Biometry (IMB),TU Dresden,Dresden,Allemagne

  • Institute for Medical Informatics and Biometry (IMB),TU Dresden,Dresden,Allemagne

  • Institute for Medical Informatics and Biometry (IMB),TU Dresden,Dresden,Allemagne

  • Department of Molecular and Clinical Cancer Medicine,University of Liverpool,Liverpool,Royaume-uni

  • Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom

  • Instituto de Matemática e Computação,Universidade Federal de Itajubá,Itajubá,巴西

  • Department of Molecular and Clinical Cancer Medicine,University of Liverpool,Liverpool,Royaume-uni

  • Instituto de Matemática e Computação,Universidade Federal de Itajubá,Itajubá,巴西

  • Instituto de Matemática e Computação,Universidade Federal de Itajubá,Itajubá,巴西

  • Institute for Medical Informatics and Biometry, Munich, Germany

  • Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom

Locations

  • Germany

  • United Kingdom

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved